Company
Ultragenyx Pharmaceutical Inc. (RARE)
Standardized SEC financial data for Ultragenyx Pharmaceutical Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001515673 · NASDAQ · Pharmaceutical Preparations.
Gross margin
7.5%
Operating margin
-79.5%
Net margin
-85.4%
Revenue growth (YoY)
20.2%
Return on equity
718.8%
Free cash flow
-$472.0M
Current ratio
2.48×
EPS (diluted)
$-5.83
Ratios for fiscal year 2025, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $271.0M | $351.4M | $363.3M | $434.0M | $560.0M | $673.0M |
| R&D expense |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $713.5M | $307.6M | $132.9M | $214.0M | $174.0M | $421.0M |
| Inventory |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$132.2M | -$338.7M | -$380.5M | -$475.0M | -$414.0M | -$466.0M |
| Capital expenditures |
Get RARE data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/RARE/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/RARE/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"